Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45,768 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glial fibrillary acidic protein (GFAP) is a novel biomarker for the prediction of autoimmune diabetes.
Pang Z, Kushiyama A, Sun J, Kikuchi T, Yamazaki H, Iwamoto Y, Koriyama H, Yoshida S, Shimamura M, Higuchi M, Kawano T, Takami Y, Rakugi H, Morishita R, Nakagami H. Pang Z, et al. Among authors: sun j. FASEB J. 2017 Sep;31(9):4053-4063. doi: 10.1096/fj.201700110R. Epub 2017 May 25. FASEB J. 2017. PMID: 28546444
Thus, these results indicate that autoantibodies against GFAP could serve as a predictive marker for the development of overt autoimmune diabetes.-Pang, Z., Kushiyama, A., Sun, J., Kikuchi, T., Yamazaki, H., Iwamoto, Y., Koriyama, H., Yoshida, S., Shimamura, M., Hig …
Thus, these results indicate that autoantibodies against GFAP could serve as a predictive marker for the development of overt autoimmune dia …
A novel angiotensin II peptide vaccine without an adjuvant in mice.
Nakamaru R, Nakagami H, Hayashi H, Sun J, Tenma A, Yamamoto K, Shimamura M, Morishita R, Rakugi H. Nakamaru R, et al. Among authors: sun j. J Hypertens. 2021 Jan;39(1):181-189. doi: 10.1097/HJH.0000000000002597. J Hypertens. 2021. PMID: 32667158 Free PMC article.
Preclinical study of a DNA vaccine targeting SARS-CoV-2.
Hayashi H, Sun J, Yanagida Y, Otera T, Kubota-Koketsu R, Shioda T, Ono C, Matsuura Y, Arase H, Yoshida S, Nakamaru R, Ju N, Ide R, Tenma A, Kawabata S, Ehara T, Sakaguchi M, Tomioka H, Shimamura M, Okamoto S, Amaishi Y, Chono H, Mineno J, Komatsuno T, Saito Y, Rakugi H, Morishita R, Nakagami H. Hayashi H, et al. Among authors: sun j. Curr Res Transl Med. 2022 Sep;70(4):103348. doi: 10.1016/j.retram.2022.103348. Epub 2022 Apr 20. Curr Res Transl Med. 2022. PMID: 35489099 Free PMC article.
Phase I Study to Assess the Safety and Immunogenicity of an Intradermal COVID-19 DNA Vaccine Administered Using a Pyro-Drive Jet Injector in Healthy Adults.
Nakagami H, Hayashi H, Sun J, Yanagida Y, Otera T, Nakagami F, Hamaguchi S, Yoshida H, Okuno H, Yoshida S, Nakamaru R, Yokoyama S, Fujimoto T, Hongyo K, Akeda Y, Morishita R, Tomono K, Rakugi H. Nakagami H, et al. Among authors: sun j. Vaccines (Basel). 2022 Aug 30;10(9):1427. doi: 10.3390/vaccines10091427. Vaccines (Basel). 2022. PMID: 36146505 Free PMC article.
45,768 results
You have reached the last available page of results. Please see the User Guide for more information.